{"id":"NCT00304356","sponsor":"Daniel M. Musher MD","briefTitle":"Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile Infection","officialTitle":"Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile Colitis in Patients Who Have Failed Conventional Therapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2004-01","primaryCompletion":"2007-01","completion":"2007-01","firstPosted":"2006-03-17","resultsPosted":"2017-12-15","lastUpdate":"2017-12-15"},"enrollment":22,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Clostridium Enterocolitis","Pseudomembranous Colitis"],"interventions":[{"type":"DRUG","name":"Nitazoxanide","otherNames":["alinia"]}],"arms":[{"label":"active drug","type":"OTHER"}],"summary":"The purpose of this study is for compassionate use of nitazoxanide in the treatment of diarrheal disease due to Clostridium difficile infection when the patient has failed previous treatment with metronidazole or vancomycin.","primaryOutcome":{"measure":"Nitazoxanide","timeFrame":"30 days","effectByArm":[{"arm":"Nitazoxanide","deltaMin":27,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":5},"locations":{"siteCount":2,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":27},"commonTop":[]}}